Case 134: Update 2

Considering our patient’s age and overall fitness, the MDT decides to offer him CHOP chemotherapy. He tolerates this well with no significant toxicities.

Mid treatment PET shows progressive disease with new lymphadenopathy in the mediastinum.

How does this change your management?

About TeamHaem

Online education and discussion about all things haematological
This entry was posted in Uncategorised. Bookmark the permalink.